Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
27.09
-1.82 (-6.30%)
At close: Dec 5, 2025, 4:00 PM EST
27.18
+0.09 (0.33%)
After-hours: Dec 5, 2025, 7:58 PM EST
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.67 billion as of December 5, 2025. Its market cap has increased by 32.82% in one year.
Market Cap
2.67B
Enterprise Value
1.75B
1-Year Change
32.82%
Ranking
Category
Stock Price
$27.09
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.67B, an increase of 715.19%. That is a compound annual growth rate of 43.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.67B | 35.45% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |